Quantum Biopharma Ltd. Files Form 6-K
Ticker: QNTM · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jul 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, compliance
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 7/22/25, standard reporting for Canadian company.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 22, 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is reporting as a foreign private issuer for the month of July 2025. Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates ongoing reporting compliance for Quantum Biopharma Ltd. as a foreign private issuer, which is standard for companies listed on US exchanges but based internationally.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate increased risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- July 22, 2025 (date) — Filing date of the Form 6-K
- Toronto, Canada (location) — Location of principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange on which its securities are traded, or distributes or is required to distribute to its security holders.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
Quantum Biopharma Ltd.'s principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario, M5J2H7, Canada.
Does Quantum Biopharma Ltd. file an annual report on Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files or will file annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding Quantum Biopharma Ltd. (QNTM).